相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The next chapter for group B meningococcal vaccines
N. Y. Wang et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2018)
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
Ray Borrow et al.
EXPERT REVIEW OF VACCINES (2017)
Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative
Ray Borrow et al.
JOURNAL OF INFECTION (2017)
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data
Caroline L. Trotter et al.
LANCET INFECTIOUS DISEASES (2017)
Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada
Philippe De Wals et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants An Open, Randomized Trial
Jose Manuel Merino Arribas et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine
Amanda C. Cohn et al.
PEDIATRICS (2017)
Modelling the cost-effectiveness of catch-up 'MenB' (Bexsero) vaccination in England
Hannah Christensen et al.
VACCINE (2017)
Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa
Idris Mohammed et al.
PATHOGENS AND GLOBAL HEALTH (2017)
Serogroup B Meningococcus Outbreaks, Prevalence, and the Case for Standard Vaccination
James Grogan et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016
Monica E. Patton et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational Study
Thomas Benet et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Enter B and W: two new meningococcal vaccine programmes launched
Shamez N. Ladhani et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2016)
Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?
Jamie Findlow
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Genomic Investigation Reveals Highly Conserved, Mosaic, Recombination Events Associated with Capsular Switching among Invasive Neisseria meningitidis Serogroup W Sequence Type (ST)-11 Strains
Mustapha M. Mustapha et al.
GENOME BIOLOGY AND EVOLUTION (2016)
Prevention of meningococcal disease during the Hajj and Umrah mass gatherings: past and current measures and future prospects
Saber Yezli et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines
Stephen I. Pelton
JOURNAL OF ADOLESCENT HEALTH (2016)
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
Sydel R. Parikh et al.
LANCET (2016)
Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data
Fati Sidikou et al.
LANCET INFECTIOUS DISEASES (2016)
Immunogenicity of a Meningococcal B Vaccine during a University Outbreak
Nicole E. Basta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
National surveillance for meningococcal disease in Japan, 1999-2014
Munehisa Fukusumi et al.
VACCINE (2016)
Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative
Ray Borrow et al.
VACCINE (2016)
Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants
Roger Baxter et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence
Aia Assaf-Casals et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Issues in pediatric vaccine-preventable diseases in low- to middle-income countries
Ghassan Dbaibo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Bacterial agents causing meningitis during 2013-2014 in Turkey: A multi-center hospital-based prospective surveillance study
Mehmet Ceyhan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero (R)) against meningococcal B disease: A cost-effectiveness analysis
Roberto Gasparini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
The importance of surveillance: Group W meningococcal disease outbreak response and control in England
Helen Campbell et al.
INTERNATIONAL HEALTH (2016)
Meningococcal B vaccination: real-world experience and future perspectives
Parvane Kuhdari et al.
PATHOGENS AND GLOBAL HEALTH (2016)
Meningococcal Vaccinations
Nancy Crum-Cianflone et al.
INFECTIOUS DISEASES AND THERAPY (2016)
Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso
Anais Colombini et al.
CLINICAL INFECTIOUS DISEASES (2015)
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India
Prasad S. Kulkarni et al.
CLINICAL INFECTIOUS DISEASES (2015)
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013
Clement Lingani et al.
CLINICAL INFECTIOUS DISEASES (2015)
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis
Li Liu et al.
LANCET (2015)
Pneumococcal vaccines and the prevention of community-acquired pneumonia
Susanna Esposito et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations
Marco Aurelio P. Safadi et al.
VACCINE (2015)
Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013
Michael Broeker et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
Jessica R. MacNeil et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales
Shamez N. Ladhani et al.
CLINICAL INFECTIOUS DISEASES (2015)
Evolving meningococcal immunization strategies
Marco Aurelio Safadi et al.
EXPERT REVIEW OF VACCINES (2015)
Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America
R. Abad et al.
EPIDEMIOLOGY AND INFECTION (2014)
Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study
Rodrigo Lopez Castelblanco et al.
LANCET INFECTIOUS DISEASES (2014)
Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin
Simona Zipursky et al.
VACCINE (2014)
Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005-2012 in Turkey A multicenter prospective surveillance study
Mehmet Ceyhan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Review of meningococcal vaccines with updates on immunization in adults
Yorgo C. Zahlanie et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Global practices of meningococcal vaccine use and impact on invasive disease
Asad Ali et al.
PATHOGENS AND GLOBAL HEALTH (2014)
Meningococcal Disease: Epidemiology and Early Effects of Immunization Programs
M. A. P. Safadi et al.
Journal of the Pediatric Infectious Diseases Society (2014)
Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
Paul A. Kristiansen et al.
CLINICAL INFECTIOUS DISEASES (2013)
Outbreak of Neisseria meningitidis C in a Brazilian oil refinery involving an adjacent community
Bernadete L. Liphaus et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2013)
The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative
Marco Aurelio P. Safadi et al.
EXPERT REVIEW OF VACCINES (2013)
Meningococcal Serogroup A, C, W135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
Hiltsje Hepkema et al.
PLOS ONE (2013)
Description and Nomenclature of Neisseria meningitidis Capsule Locus
Odile B. Harrison et al.
EMERGING INFECTIOUS DISEASES (2013)
Global epidemiology of invasive meningococcal disease
Rabab Z. Jafri et al.
POPULATION HEALTH METRICS (2013)
Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attention
Mehmet Ceyhan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Progress and challenges in bacterial meningitis
Diederik van de Beek
LANCET (2012)
Can we defeat meningococcal disease in low and middle income countries?
Brian Greenwood et al.
VACCINE (2012)
Meningococcal disease: Clinical presentation and sequelae
David Pace et al.
VACCINE (2012)
The changing and dynamic epidemiology of meningococcal disease
Scott A. Halperin et al.
VACCINE (2012)
Importance of circulating antibodies in protection against meningococcal disease
Kim S. Erlich et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Meningococcal disease: changes in epidemiology and prevention
David Stephens et al.
Clinical Epidemiology (2012)
Trends in Meningococcal Disease in the United States Military, 1971-2010
Michael P. Broderick et al.
EMERGING INFECTIOUS DISEASES (2012)
Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region
Atef Shibl et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2012)
Meningococcal disease in Asia: an under-recognized public health burden
A. Vyse et al.
EPIDEMIOLOGY AND INFECTION (2011)
Neisseria meningitidis B vaccines
Donatella Panatto et al.
EXPERT REVIEW OF VACCINES (2011)
Meningococcal glycoconjugate vaccines
Roberto Gasparini et al.
HUMAN VACCINES (2011)
Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil
Patricia Coelho de Soarez et al.
VALUE IN HEALTH (2011)
Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease
Michael Broeker et al.
Infection and Drug Resistance (2011)
Community acquired bacterial meningitis in Cuba: a follow up of a decade
Antonio E. Perez et al.
BMC INFECTIOUS DISEASES (2010)
Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity
Helen Campbell et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease
Amanda C. Cohn et al.
CLINICAL INFECTIOUS DISEASES (2010)
Prevention of Meningococcal Disease: Current Use of Polysaccharide and Conjugate Vaccines
Gregory A. Poland
CLINICAL INFECTIOUS DISEASES (2010)
The epidemiology of meningococcal disease and the impact of vaccines
Ameneh Khatami et al.
EXPERT REVIEW OF VACCINES (2010)
Meningococcal carriage by age: a systematic review and meta-analysis
Hannah Christensen et al.
LANCET INFECTIOUS DISEASES (2010)
Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis
Karen Edmond et al.
LANCET INFECTIOUS DISEASES (2010)
Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention
Marco Aurelio Palazzi Safadi et al.
NEUROLOGICAL RESEARCH (2010)
CURRENT CONCEPTS Advances in the Development of Vaccines against Neisseria meningitidis
Lionel K. K. Tan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Modeling the Cost-Effectiveness of the Integrated Disease Surveillance and Response (IDSR) System: Meningitis in Burkina Faso
Zana C. Somda et al.
PLOS ONE (2010)
The epidemiology of meningococcal disease in India
David Sinclair et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
Childhood Bacterial Meningitis in Ulaanbaatar, Mongolia, 2002-2004
Jamsran Mendsaikhan et al.
CLINICAL INFECTIOUS DISEASES (2009)
Global epidemiology of meningococcal disease
Lee H. Harrison et al.
VACCINE (2009)
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States
Ismael R. Ortega-Sanchez et al.
CLINICAL INFECTIOUS DISEASES (2008)
A prospective study of etiology of childhood acute bacterial meningitis, Turkey
Mehmet Ceyhan et al.
EMERGING INFECTIOUS DISEASES (2008)
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
Nilima Kshirsagar et al.
VACCINE (2007)
Comparative study of meningitis dynamics across nine African countries:: a global perspective
Helene Broutin et al.
INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS (2007)
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
David S. Stephens et al.
LANCET (2007)
Meningococcal disease and meningitis
Ricardo G. Branco et al.
JORNAL DE PEDIATRIA (2007)
Use of meningococcal vaccines in the United States
Oleg Bilukha et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998-2004)
S. Afifi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Meningococcal disease and its management in children
C. Anthony Hart et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan
CS Chiou et al.
BMC INFECTIOUS DISEASES (2006)
Clinical recognition of meningococcal disease in children and adolescents
MJ Thompson et al.
LANCET (2006)
Bacterial meningitis in children and adolescents:: an observational study based on the national surveillance system -: art. no. 103
FO Dickinson et al.
BMC INFECTIOUS DISEASES (2005)
Rotavirus vaccines: Targeting the developing world
RI Glass et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
CW Shepard et al.
PEDIATRICS (2005)
Polysaccharide vaccines for preventing serogroup A meningococcal meningitis
M Patel et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
CL Trotter et al.
LANCET (2004)
Effectiveness of meningococcal C conjugate vaccine in teenagers in England
A Bose et al.
LANCET (2003)
Vaccinating first-year college students living in dormitories for meningococcal disease - An economic analysis
RD Scott et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2002)
Risk factors for meningococcal disease in college students
MG Bruce et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa:: a theoretical modeling analysis
IP du Châtelet et al.
VACCINE (2001)
Risk factors for meningococcal disease in university halls of residence
SJ Nelson et al.
EPIDEMIOLOGY AND INFECTION (2001)
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
ME Ramsay et al.
LANCET (2001)
分享论文
